Visual Acuity Recovery After Macular Hole Closure Associated With Foveal Avascular Zone Change.

foveal avascular zone macular hole optical coherence tomography angiography vitrectomy

Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
07 2020
Historique:
received: 23 03 2020
accepted: 06 06 2020
entrez: 29 8 2020
pubmed: 29 8 2020
medline: 29 8 2020
Statut: epublish

Résumé

To evaluate changes in the foveal avascular zone (FAZ) area during the postoperative period of macular hole (MH) surgery using the optical coherence tomography angiography (OCTA) and to investigate its relationship to visual acuity (VA). Consecutive unilateral MH patients who underwent successful MH closure with at least a six-month observation period were studied retrospectively. To evaluate the FAZ area, OCTA images were obtained at the preoperative visit, the first postoperative visit, and the six-month visit. Main outcome measures were postoperative FAZ change and its relationship to VA change after MH closure. Fifty-one cases were studied. The FAZ area was 0.42 ± 0.11 mm The FAZ area once decreases along with MH closure; it thereafter increases toward the normal value over time. The postoperative FAZ change was correlated with the VA recovery. This study suggests that the postoperative FAZ area enlargement might be a potential biomarker indicating foveal reconstruction after MH closure.

Identifiants

pubmed: 32855867
doi: 10.1167/tvst.9.8.20
pii: TVST-20-2441
pmc: PMC7422767
doi:

Types de publication

Journal Article

Langues

eng

Pagination

20

Informations de copyright

Copyright 2020 The Authors.

Déclaration de conflit d'intérêts

Disclosure: K. Tsuboi, None; A. Fukutomi, None; H. Sasajima, None; Y. Ishida, None; K. Kusaba, None; T. Kataoka, None; M. Kamei, HOYA Surgical Optics (F), Abbott Medical Optics (F), Novartis Pharma KK (F), Pfizer Japan, Inc. (F), HANDAYA Co., Ltd. (F), TOMEY Co., Ltd. (F), Kowa Co., Ltd (F), Santen Co., Ltd. (F), Senju Co., Ltd. (F), Otsuka Co., Ltd. (F), and Alcon Japan Ltd. (F)

Références

Am J Ophthalmol. 2014 May;157(5):971-7
pubmed: 24503409
Invest Ophthalmol Vis Sci. 2011 Feb 01;52(1):625-34
pubmed: 20861480
Am J Ophthalmol. 2000 Aug;130(2):192-6
pubmed: 11004293
Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):1923-1934
pubmed: 28744658
Ophthalmology. 1994 Apr;101(4):682-6
pubmed: 8152763
Ophthalmology. 2017 Jul;124(7):944-952
pubmed: 28318637
Invest Ophthalmol Vis Sci. 2010 Aug;51(8):3913-8
pubmed: 20357206
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT130-40
pubmed: 27409463
JAMA Ophthalmol. 2017 Apr 1;135(4):299-305
pubmed: 28208188
Invest Ophthalmol Vis Sci. 2011 Jul 25;52(8):5541-50
pubmed: 21642620
Am J Ophthalmol. 2006 Mar;141(3):589-91
pubmed: 16490523
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5105-10
pubmed: 21803966
Transl Vis Sci Technol. 2018 Oct 1;7(5):20
pubmed: 30280005
Am J Ophthalmol. 2000 Jun;129(6):769-77
pubmed: 10926987
Invest Ophthalmol Vis Sci. 2012 Mar 21;53(3):1628-36
pubmed: 22323466
Br J Ophthalmol. 2019 Feb;103(2):238-244
pubmed: 29632001
Retina. 2017 Mar;37(3):444-450
pubmed: 28225721
Am J Ophthalmol. 2018 May;189:111-121
pubmed: 29505776
Retina. 2007 Jan;27(1):95-100
pubmed: 17218922
Clin Exp Ophthalmol. 2008 Apr;36(3):257-60
pubmed: 18412595
Acta Ophthalmol. 2020 Jun;98(4):e447-e456
pubmed: 31654489
Ophthalmology. 2009 Dec;116(12):2430-6
pubmed: 19744721
Arch Ophthalmol. 1991 May;109(5):654-9
pubmed: 2025167
Invest Ophthalmol Vis Sci. 2013 Jul 18;54(7):4882-91
pubmed: 23800766
Transl Vis Sci Technol. 2019 Jan 18;8(1):10
pubmed: 30687581
Ophthalmology. 2000 Oct;107(10):1939-48; discussion 1948-9
pubmed: 11013203
Eye (Lond). 2010 Dec;24(12):1787-91
pubmed: 20829889
Invest Ophthalmol Vis Sci. 2013 Jan 21;54(1):629-35
pubmed: 23299482
Ophthalmol Retina. 2019 Mar;3(3):237-243
pubmed: 31014700
Retina. 2000;20(3):232-7
pubmed: 10872926
Invest Ophthalmol Vis Sci. 2014 May 06;55(5):3003-11
pubmed: 24736052
Am J Ophthalmol. 2001 Feb;131(2):203-7
pubmed: 11228296
Retina. 2018 Sep;38(9):1699-1706
pubmed: 28699926
Invest Ophthalmol Vis Sci. 2014 Sep 30;55(10):6870-7
pubmed: 25270194
Ophthalmology. 2010 Sep;117(9):1815-24
pubmed: 20472291
Am J Ophthalmol. 2015 Nov;160(5):990-999.e1
pubmed: 26297503
Ophthalmology. 2009 Jul;116(7):1366-9
pubmed: 19576500
Br J Ophthalmol. 2003 Aug;87(8):1015-9
pubmed: 12881347
Eye (Lond). 2015 Mar;29(3):388-96
pubmed: 25572579

Auteurs

Kotaro Tsuboi (K)

Department of Ophthalmology, Aichi Medical University, Nagakute, Japan.

Akira Fukutomi (A)

Department of Ophthalmology, Aichi Medical University, Nagakute, Japan.

Hirofumi Sasajima (H)

Department of Ophthalmology, Aichi Medical University, Nagakute, Japan.

Yuichiro Ishida (Y)

Department of Ophthalmology, Aichi Medical University, Nagakute, Japan.

Kiichiro Kusaba (K)

Department of Ophthalmology, Aichi Medical University, Nagakute, Japan.

Takuya Kataoka (T)

Department of Ophthalmology, Aichi Medical University, Nagakute, Japan.

Motohiro Kamei (M)

Department of Ophthalmology, Aichi Medical University, Nagakute, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH